News - Legal, Licensing


Current filters:


Popular Filters

Takeda returns veltuzumab rights to Immunomedics

Takeda returns veltuzumab rights to Immunomedics


Immunomedics says it has received notification from Takeda Pharmaceutical, Japan’s largest drugmaker,…

GlobalLegalLicensingNycomedOtsukaPharmaceuticalTakeda Pharmaceuticalsveltuzumab

Nuvo Research files law suit against Mallinckrodt


Canadian specialty pharma company Nuvo Research (TSX: NRI) says it has commenced legal action against…

Anti-Arthritics/RheumaticsLegalLicensingMallinckrodtNorth AmericaNuvo ResearchPennsaidPharmaceutical

US FTC will continue to challenge "anticompetitive" pharma pay-for-delay deals


The Federal Trade Commission told a Senate Judiciary subcommittee yesterday (July 23) that it will continue…

GenericsLegalLicensingMarkets & MarketingNorth AmericaPharmaceutical

News briefs: Celgene deal with Sutro; Amgen pleads guilty to misbranding


US biotech firm Celgene Corp (Nasdaq: CELG) has entered a collaboration with San Francisco-based Sutra…

AmgenAranespBiotechnologyCelgeneFinancialLegalLicensingNorth AmericaSutro Biopharma

Alnylam and Tekmira restructure relationship and settle all litigation in $65 million deal


USA-based Alnylam Pharmaceuticals (Nasdaq: ALNY) says it has restructured its relationship with Canadian…

Alnylam PharmaceuticalsBiotechnologyFinancialLegalLicensingPharmaceuticalTekmira Pharmaceuticals

Sucampo fails in Amitiza arbitration with Takeda


US drugmaker Sucampo Pharmaceuticals (Nasdaq: SCMP) says that it has received a final binding decision…

AmitizaLegalLicensingPharmaceuticalResculaSucampoTakeda Pharmaceuticals

Takeda ends Daxas co-promotion with MSD; Actos law suits


Japan’s largest drugmaker, Takeda Pharmaceuticals (TYO: 4502) says that it has reached a mutual…

ActosDaxasDiabetesLegalLicensingMerck & CoNycomedPharmaceuticalRespiratory and PulmonaryTakeda Pharmaceuticals

Salix files Crofelemer NDA as spat with Napo moves to Glenmark


USA-based Salix Pharmaceuticals (Nasdaq) said yesterday that it has submitted a New Drug Application…

crofelemerGastro-intestinalsGlenmark PharmaceuticalsLegalLicensingNapo PharmaceuticalsPharmaceuticalRegulationSalix Pharmaceuticals

Actelion to appeal even though US court cuts original verdict by nearly $170 million in dispute with Asahi


Despite a final judgement issued on Friday by the Superior Court of the State of California, USA, to…

ActelionAsahi KaseiBiotechnologyfasudilFinancialLegalLicensing

Bayer settles with Onyx over Nexavar and regorafenib with $160 million payment


US drugmaker Onyx Pharmaceuticals (Nasdaq: ONXX) and German pharma major Bayer HealthCare, a unit of…

BayerLegalLicensingNexavarOncologyOnyx PharmaceuticalsPharmaceuticalregorafenib

Mylan enters settlement and license deal with Roche over Xeloda


US generic drugs giant Mylan (Nasdaq: MYL) says that it has entered into a settlement and license agreement…

GenericsLegalLicensingMylan LaboratoriesNorth AmericaOncologyRocheXeloda

Pfizer in generic Lipitor deals with Sanofi and Dr Reddy’s


Global drugs behemoth Pfizer (NYSE: PFE) has reached agreement with French drug major Sanofi (Euronext:…

atorvastatinCardio-vascularDr Reddy's LaboratoriesGenericsLegalLicensingLipitorPfizerSanofiZentiva

Back to top